Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Rybelsus. Rybelsus is a daily pill FDA-approved for diabetes but sometimes prescribed off-label for weight loss. As with brand-name versions of semaglutide, there’s no magic number for how long ...

A decision is expected in the fourth quarter of 2025.

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Lastly, if you’re on or about to get on one of the new weight loss drugs, walk the walk and be patient. It took you quite a ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found that tens of thousands of Americans have ended up in the emergency room from ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.